Loading...
Topiramate’s Reduction of Body Mass Index in Heavy Drinkers: Lack of Moderation by a GRIK1 Polymorphism
Topiramate, which interacts with multiple neurotransmitter and enzyme systems, is approved by the Food and Drug Administration to treat seizure disorder, prevent migraine, and (in combination with phentermine) reduce weight. Topiramate has also been shown in multiple studies to reduce heavy drinking...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4180772/ https://ncbi.nlm.nih.gov/pubmed/24978347 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1037/a0037309 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|